Related Experiment Video
Updated: Jun 9, 2025

08:56
Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
Published on: May 17, 2018
9.1K
[Chronic fatigue syndrome in children]
L S Chutko1, S Yu Surushkina1, E A Yakovenko1
1N. Bechtereva Institute of the Human Brain, St. Petersburg, Russia.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|October 22, 2024
Summary
This review examines chronic fatigue syndrome (CFS) in children and adults, covering its epidemiology, causes, diagnosis, and clinical features. It highlights neurocognitive deficits and explores potential treatments for pediatric CFS.
Area of Science:
- Neurology
- Pediatrics
- Immunology
Background:
- Chronic Fatigue Syndrome (CFS) is a complex, debilitating disorder affecting both children and adults.
- Understanding the epidemiology, etiology, and pathogenesis of CFS is crucial for effective management.
- Existing research presents varied perspectives on CFS, necessitating a comprehensive overview.
Purpose of the Study:
- To review scientific literature on Chronic Fatigue Syndrome (CFS).
- To summarize current knowledge on CFS epidemiology, etiology, pathogenesis, and diagnosis.
- To detail clinical manifestations, neurocognitive deficits, and treatment strategies for pediatric CFS.
Main Methods:
- Systematic review of scientific publications on CFS.
- Analysis of studies focusing on epidemiology in children and adults.
- Evaluation of research on CFS etiology, pathogenesis, diagnostic criteria, and clinical features.
- Inclusion of studies on neurocognitive deficits and treatment approaches in pediatric CFS.
Main Results:
- Epidemiological data for CFS in both pediatric and adult populations were reviewed.
- Diverse etiological factors and pathogenetic mechanisms of CFS were presented.
- Current diagnostic criteria and specific clinical manifestations in children were outlined.
- Key neurocognitive deficits in pediatric CFS and therapeutic interventions were discussed.
Conclusions:
- A comprehensive understanding of CFS requires integrating epidemiological, etiological, and clinical findings.
- Accurate diagnosis and tailored treatment are essential for managing CFS, particularly in children.
- Further research into neurocognitive deficits and effective therapies for pediatric CFS is warranted.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
46
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
46
Muscle Recovery and Fatigue
2.0K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.0K
Cystic Fibrosis: Pathogenesis
192
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
192
Cystic Fibrosis: Management
143
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
143
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Narcolepsy
92
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
92

